About 1 result found for searched term "Ladarixin sodium" (0.141 seconds)
Cat.No. | Name | Target |
---|---|---|
M30746 | Ladarixin sodium | CXCR |
DF 2156A | ||
Ladarixin sodium (DF 2156A) is an orally active, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist. Ladarixin sodium can be used for the research of COPD and asthma. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.